Amine-reactive isobaric tagging reagents: Requirements for absolute quantification of proteins and peptides

2008 ◽  
Vol 379 (2) ◽  
pp. 164-169 ◽  
Author(s):  
M. Quaglia ◽  
C. Pritchard ◽  
Z. Hall ◽  
G. O’Connor
2015 ◽  
Vol 11 (5) ◽  
pp. 1400-1409 ◽  
Author(s):  
QingMing Kong ◽  
QunBo Tong ◽  
Di Lou ◽  
JianZu Ding ◽  
Bin Zheng ◽  
...  

We applied isobaric tagging reagents for relative and absolute quantification analyses to investigate the effect of artesunate on the proteome ofSchistosoma japonicumin susceptible mice.


2018 ◽  
Author(s):  
William D Mitchell ◽  
Rowan P Orme ◽  
Sarah R Hart ◽  
Rosemary A Fricker

Parkinson’s disease is a widespread condition caused by degeneration of dopamine neurons in the midbrain. A number of proteins are known to be important to signalling mechanisms present in the midbrain during natural dopamine neuron development, and may be utilised to better produce dopamine neurons in vitro. Relative expression levels of proteins were obtained from substantia nigra tissue of rats from embryonic days E11 through E14 using isobaric tagging for relative and absolute quantification. This project analysed the dataset obtained, with an emphasis on relative expression levels of proteins across the four-day period. Bioinformatics searching of online databases reduced the dataset from 3325 proteins to a shortlist of five worthy of further investigation. It is hoped that the proteins identified using these techniques will help to refine protocols for the production of dopamine neurons in vitro.


2009 ◽  
Vol 55 (11) ◽  
pp. 1984-1990 ◽  
Author(s):  
Caroline Pritchard ◽  
Milena Quaglia ◽  
Chris Mussell ◽  
William I Burkitt ◽  
Helen Parkes ◽  
...  

Abstract Background: Measurement traceability in clinical chemistry is required to standardize clinical results irrespective of the measurement procedure and laboratory. The traceability of many protein substances is maintained by reference to the first standard produced, which may no longer exist, with values assigned by consensus. Independent methods that provide traceability to the Système d’Unité International for all relevant properties of a protein standard could remove reliance on the original standard preparations. Methods: We developed a method based on the traceable quantification of tryptic peptides released from the protein by isotope dilution mass spectrometry to compare 2 standard preparations of somatropin (recombinant human growth hormone), WHO 98/574 and Ph.Eur.CRS S0947000. Relative quantification using isotope-coded affinity tagging, isobaric tagging for relative and absolute quantification, and standard additions were also performed to validate the digestion method used and to determine whether any modifications were present. Results: The total somatropin content in both materials was determined and an uncertainty estimation undertaken [WHO 2.19 ± 0.21) mg/vial, European Pharmacopeia 2.06 ± 0.21 mg/vial]. Each uncertainty in this paper is a fully estimated uncertainty, with 95% CI (k = 2). Isotope coded affinity tag and standard addition results fully validated the robustness of the digestion method used. In addition, iTRAQ (isobaric tagging for relative and absolute quantification analysis) identified 2 modifications, neither of which impacted the quantification. Conclusions: An independent method that does not rely on a preexisting protein standard has been developed and validated for the traceable value-assignment of total somatropin. The methods reported here address the amount of substance (mass fraction) of the standard materials but address neither biological activity nor other characteristics that may be important in assessing suitability for use as a calibrator.


2018 ◽  
Author(s):  
William D Mitchell ◽  
Rowan P Orme ◽  
Sarah R Hart ◽  
Rosemary A Fricker

Parkinson’s disease is a widespread condition caused by degeneration of dopamine neurons in the midbrain. A number of proteins are known to be important to signalling mechanisms present in the midbrain during natural dopamine neuron development, and may be utilised to better produce dopamine neurons in vitro. Relative expression levels of proteins were obtained from substantia nigra tissue of rats from embryonic days E11 through E14 using isobaric tagging for relative and absolute quantification. This project analysed the dataset obtained, with an emphasis on relative expression levels of proteins across the four-day period. Bioinformatics searching of online databases reduced the dataset from 3325 proteins to a shortlist of five worthy of further investigation. It is hoped that the proteins identified using these techniques will help to refine protocols for the production of dopamine neurons in vitro.


2018 ◽  
Author(s):  
William D Mitchell ◽  
Rowan P Orme ◽  
Sarah R Hart ◽  
Rosemary A Fricker

Parkinson’s disease is a widespread condition caused by degeneration of dopamine neurons in the midbrain. A number of proteins are known to be important to signalling mechanisms present in the midbrain during natural dopamine neuron development, and may be utilised to better produce dopamine neurons in vitro. Relative expression levels of proteins were obtained from substantia nigra tissue of rats from embryonic days E11 through E14 using isobaric tagging for relative and absolute quantification. This project analysed the dataset obtained, with an emphasis on relative expression levels of proteins across the four-day period. Bioinformatics searching of online databases reduced the dataset from 3325 proteins to a shortlist of five worthy of further investigation. It is hoped that the proteins identified using these techniques will help to refine protocols for the production of dopamine neurons in vitro.


Author(s):  
Jessica C. A. Bouma-ter Steege ◽  
Kevin H. Mayo ◽  
Arjan W. Griffioen

Sign in / Sign up

Export Citation Format

Share Document